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Abstract:  
 
Resident adipose tissue macrophages (ATMs) play multiple roles to maintain tissue homeostasis, 
such as removing excess free fatty acids and regulation of the extracellular matrix. The 
phagocytic nature and oxidative resiliency of macrophages not only allows them to function as 
innate immune cells but also to respond to specific tissue needs, such as iron homeostasis. MFehi 
ATMs are a subtype of resident ATMs that we recently identified to have twice the intracellular 
iron content as other ATMs and elevated expression of iron-handling genes. Although studies 
have demonstrated that iron homeostasis is important for adipocyte health, little is known about 
how MFehi ATMs may respond to and influence adipose tissue iron availability. Two 
methodologies were used to address this question: dietary iron supplementation and 
intraperitoneal iron injection. Upon exposure to high dietary iron, MFehi ATMs accumulated 
excess iron, whereas the iron content of MFelo ATMs and adipocytes remained unchanged. In 
this model of chronic iron excess, MFehi ATMs exhibited increased expression of genes involved 
in iron storage. In the injection model, MFehi ATMs incorporated high levels of iron, and 
adipocytes were spared iron overload. This acute model of iron overload was associated with 
increased numbers of MFehi ATMs; 17% could be attributed to monocyte recruitment and 83% 
to MFelo ATM incorporation into the MFehi pool. The MFehi ATM population maintained its low 
inflammatory profile and iron-cycling expression profile. These studies expand the field’s 
understanding of ATMs and confirm that they can respond as a tissue iron sink in models of iron 
overload. 
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Introduction  
 
Adipose tissue (AT) has many different functions, primary among which is the inert 
storage of fatty acids as a caloric reservoir. To respond to metabolic demand appropriately, 
adipocytes are in reciprocal communication with other tissues via systemic hormones (e.g., 
insulin, leptin, adiponectin). Under normal conditions, adipocytes are able to metabolize, store, 
and synthesize lipids without lipotoxicity (20). Within the last decade, interest in AT has 
expanded as it becomes clear that local adipocyte physiology, such as oxidative stress or 
inflammation levels, can have beneficial or detrimental effects systemically. 
 Immune cells play an important supportive role for adipocytes in the AT 
microenvironment. The most prominent AT-associated immune cells, AT macrophages (ATMs), 
are intercalated throughout the tissue matrix in close contact with individual adipocytes. ATMs 
were first identified in the context of obese AT, in which metabolically inflamed ATMs [Mme, 
described by Kratz (13)] accumulate and induce chronic inflammation (15, 30, 31). However, 
resident ATMs are also present in lean AT and fall on the anti-inflammatory (M2-like) end of the 
polarization spectrum. Understanding the homeostatic functions of resident M2-like ATMs in 
lean AT may provide a mechanism by which to influence the adipocyte microenvironment, 
supporting healthy AT expansion. 
 Macrophages are the primary cells responsible for handling iron in the body. Because of 
its scarcity, iron is recycled, primarily through the erythrocyte hemoglobin cycle (5). Senescent 
erythrocytes are phagocytosed, and their heme-associated iron is released as transferrin-bound 
iron. In fact, the transferrin-iron pool turns over several times daily in humans. Kupffer cells and 
splenic macrophages are primarily responsible for this turnover, which is regulated by hepcidin 
(5). M1-like inflammatory macrophages have an important iron sequestration role during 
infection. However, the field has expanded its understanding of macrophages in iron homeostasis 
beyond just M1-like macrophages in blood to include resident M2-like macrophages in tissues. 
Iron is now thought to be spatially regulated on a microenvironmental scale in muscle, spinal 
cord, and vasculature and even regulated in a time-dependent manner during wound repair (1, 7, 
14). In these studies, resident M2-like macrophages are responsible for fine-tuned iron uptake 
and release. Similar to these tissues, regulated control of iron homeostasis is important in AT for 
two reasons: 1) AT requires iron availability for healthy adipogenesis (9), and 2) unique to AT, 
excess fatty acids prevalent in the tissue can react with free iron to facilitate a lipid peroxidation 
chain reaction (28). Studies have shown that iron overload, specifically in adipocytes, can reduce 
systemic insulin sensitivity through a reduction in adiponectin (9, 33). This emphasizes the 
importance of tight regulation of iron in AT, providing the impetus to assess the role of 
macrophages in this process. 
 “MFehi” ATMs were discovered by our laboratory as resident macrophages of the AT 
that have innate ferromagnetism due to high intracellular iron content (23). Like all macro 
phages in lean AT (19), their cell-surface protein profile is representative of an M2-like, 
alternatively activated macrophage (23). This is in contrast to M1 classically activated 
inflammatory macrophages, or Mme, the metabolically activated macrophages, that infiltrate AT 
in obesity. Macrophage polarization is useful for generic classification, but, in vivo, 
macrophages span a spectrum of activation states (21). Studies have shown that macrophage 
polarization strongly influences their iron handling: broadly, M2 macrophages have an iron-
cycling phenotype, preferring iron uptake and release over inert storage (6, 17, 25, 26). Although 
all ATMs in lean AT are M2-like, when they are sorted out by ferromagnetic qualities, MFehi 
ATMs were found to have an even stronger M2 expression pattern relative to other resident M2 
“MFelo” ATMs. Reflecting this iron-cycling phenotype, MFehi have increased expression of iron 
uptake-associated genes, like the hemoglobin-haptoglobin receptor (CD163) and the transferrin 
receptor (Tfrc); iron-storage genes, like ferritin (Fth1 and Ftl1); and the primary iron-export 
gene, ferroportin (Slc40a1). However, unlike M2 macrophages polarized in vitro, MFehi ATMs 
have higher cellular iron content. Therefore, even though MFehi ATMs have an M2-like iron-
cycling phenotype based on their gene expression, their increased iron content is more reflective 
of M1-like ATMs. This contrast presents an opportunity to better understand the specific 
functional role for MFehi ATMs in regulating adipose tissue iron (11). We hypothesized that 
MFehi cells respond to iron perturbations in AT by regulating their intracellular iron pool in 
response to iron in the microenvironment and that this function is necessary to prevent adipocyte 
iron loading when excess iron is present. 
 To test this hypothesis, we looked at the response of MFehi ATMs, MFelo ATMs, and 
adipocytes in the context of two conditions of high iron: dietary iron and iron injection. Our 
studies demonstrate that MFehi ATMs increase their intracellular iron content, upregulate iron-
handling genes, and recruit macrophages, both from the MFelo population and from the 
circulation, as a compensatory response to excess iron. 
 
Materials and methods 
 
 Mice, diets, and iron injections. All animal care procedures received approval from and 
followed the guidelines of the Vanderbilt University Institutional Animal Care and Use 
Committee. Experiments used male C57BL/6J mice from The Jackson Laboratory (Bar Harbor, 
ME). Animals were fed normal chow diet (NCD) except for the groups on the special iron diets, 
in which case they were fed macronutrient-matched iron diets that contained low iron levels (35 
ppm iron; cat. no. TD-10211, Envigo), average iron (500 ppm; cat. no. TD-10212, Envigo), or 
high iron (2,000 ppm; cat. no. TD-10324, Envigo) for 8 wk starting at 8 wk of age. These dietary 
iron levels were selected because dietary iron as low as 25 ppm supports hematopoiesis in 
C57BL/6J mice, whereas around ~250 ppm is commonly found in chow diet (12, 27). Body 
weight and dietary intake were tracked, and mice were provided water and food ad libitum for 
the course of the study. For iron injection studies, mice were injected intraperitoneally (IP) with 
iron dextran-100 (Durvet), 5 mg iron/kg body weight, 1 wk before euthanization of the mice. The 
control group was injected with an equivalent volume of saline. 
 PKH26 cell stain. The PKH26 Red Fluorescent Cell Linker (Sigma) is selectively 
phagocytized by macrophages and neutrophils when they ingest the dye aggregate. The dye is 
resistant to metabolism and sustained in vivo for multiple months. This method can be used to 
stain all cells at a given time point, followed by a washout period, and any non-PKH cells are 
considered to be recruited after the time of injection. Twelve-week-old mice were injected 
intraperitoneally with 1 ml of 5 M PKH26. Control groups were injected with an equal volume 
of the diluent. Following a 2-day washout period, mice were injected with either saline or iron, 
as described 
 Glucose tolerance. Lean mass was quantified using a body composition values from the 
Minispec Model mq7.5 (Bruker). Glucose tolerance was determined by IP injection of dextrose 
at 2 mg/kg lean mass and subsequent tail vein blood glucose quantification over a 2-h time 
course. 
 SVF and adipocyte isolation. Mice were euthanized by isoflurane overdose and cervical 
dislocation, then perfused with 20 ml PBS through the left ventricle. Unless otherwise specified, 
ATMs were collected from epididymal adipose tissue (eAT). The fat pads were collected, 
minced, and digested in 6 ml of 2-mg/L type II collagenase (cat. no. C6885, Sigma) for 40 min at 
37°C. The stromal vascular fraction (SVF) was separated from adipocytes by centrifugation 
followed by erythrocyte lysis with ACK buffer, as previously described (23). The top adipocyte 
layer was transferred to a new vial and washed, then pelleted for either iron quantification or 
gene expression analysis. 
 Adipocyte size quantification. Paraffin-embedded tissues from the iron diet studies were 
sectioned and stained with toluidine blue, then digitally imaged at the Vanderbilt Digital 
Histology Core. Adipocyte area was quantified in four sections per mouse (n 4 per group) using 
a segmentation program with the MorphoLibJ plug-in of FIJI (http:// imagej.net/MorphoLibJ). 
 Magnetic sorting and fluorescence-activated cell sorting. The SVF was treated with Fc 
block (BD Biosciences) for 10 min and then stained with an appropriate combination of 
fluorophore-conjugated antibodies against cell-surface markers for 30 min at 4°C; F4/80- APC 
(eBioscience), F4/80-BV785 (BioLegend), CD11b-FITC (eBioscience), CD11b-APC/Cy7 (BD 
Biosciences), CD45-BV605 (BioLegend), CD45-PE (eBioscience), CD163-CF594 (antibody 
kindly provided by Dr. Soren Moestrup, Aarhus University, Aarhus, Denmark, conjugated using 
the Mix-n-Stain CF594 kit, Biotium). Cells were washed in fluorescence-activated cell sorter 
(FACS) buffer to make a single-cell suspension. Cells were then sorted by their ferromagnetic 
qualities through the sensitive positive selection (possel_s) program on the AutoMACS magnetic 
activated cells-sorting system (Miltenyi Biotec). After separation, the magnetic and nonmagnetic 
fractions were centrifuged at 500 g for 10 min at 4°C, resuspended with a live/dead marker 
(DAPI or prodidium iodide) and spiked with 50 L of CountBright counting beads (Thermo 
Fisher Life Science). The samples were then analyzed with either the LSRFortessa flow 
cytometer (BD Biosciences) or sorted with the FACSAria III cell sorter (BD Biosciences) with 
appropriate fluorescence minus one controls. 
 Iron visualization and quantification. Iron was visualized in paraffin-embedded eAT 
using the Perls’ Prussian blue staining method. Adipose tissue was sectioned to 10 m, cleared, 
hydrated, and stained with Prussian blue staining solution (10% hydrochloric acid, 10% Prussian 
blue) for 20 min, then counterstained with nuclear fast red for 5 min. Iron was quantified in 
MFehi and MFelo macrophages with double-focusing sector field high-resolution inductively-
coupled mass spectrometry (ICP-MS; ELEMENT II, Thermo Fisher Scientific, Bremen, 
Germany) equipped with ESI auto sampler. To quantify iron in adipocytes, the adipocyte fraction 
of the eAT fat pad was collected and pelleted, as described above. For atomic absorption 
spectrometry (AAS), samples were homogenized in 100 l radioimmunoprecipitation assay buffer 
for bicinchoninic assay protein analysis, digested in 1:2 (vol/vol) ultrapure HNO3, and further 
diluted in 2% nitric acid. Internal standardization was performed with bovine liver (184 g Fe/g; 
National Bureau of Standards, Standard Reference Material, United States Department of 
Commerce, Washington, DC). To perform ICP-MS, samples were homogenized in 2% SDS 
RIPA buffer, and an aliquot was collected to quantify protein concentration by bicinchoninic 
acid assay. The remaining sample was digested in ultra-pure HNO3 [1:3 (vol/vol) dilution] for 
12 h at 60°F, then diluted with milliQ water for ICP-MS quantification at the Vanderbilt Mass 
Spectrometry Core Laboratory. Quantification of adipocyte iron was compared between ICP-MS 
and AAS, with no significant difference found between the two methods (data not shown). 
 RNA isolation and real-time RT-PCR. Macrophages were collected via FACS as 
described above, pelleted, and resuspended in RLT buffer to allow for RNA extraction with the 
RNeasy Micro RNA kit (Qiagen), according to the manufacturers instructions. Adipocytes were 
collected as described above, but the final pellet was collected in TRIzol reagent (Invitrogen) and 
isolated with the Direct-zol RNA MiniPrep kit (Genesee). For both macrophage and adipocytes, 
cDNA was synthesized with the iScript cDNA synthesis kit (BioRad) and real-time RT-PCR was 
performed with the Taqman assay system (Applied Biosystems) on a CFX96 cycler (BioRad). 
Gene expression was normalized to glyceraldehyde-3-phosphate dehydrogenase using the 
 method. 
 Serum iron and hormone parameters. Iron, transferrin, ferritin, and total iron-binding 
capacity were quantified from serum using the ACE Alera clinical chemistry system (Alfa 
Wasserman). 
 Statistics. Data are given as means ± SE. Statistical tests were performed using GraphPad 
Prism (La Jolla, CA) by two-tailed unpaired t tests and one-way ANOVA with the Tukey 
correction for multiple comparisons, when appropriate. 
 
Results 
 
 MFehi ATMs accumulate iron with high-iron diet. On the basis of our previous 
description of the MFehi ATM ironcycling phenotype, we hypothesized that MFehi ATMs would 
respond to changes in iron concentrations in the adipose environment. We sought to determine if 
MFehi ATMs would respond to systemic changes in iron provided through a high iron diet. After 
8 wk on low-, average-, or high-iron diet, we noted systemic iron overload with increased serum 
iron and transferrin saturation (Fig. 1, A and B; P < 0.0001) but no change in hematocrit (Fig. 
1C). Varying concentrations of dietary iron caused no changes in weight gain, body composition, 
or glucose tolerance (Fig. 1, D–F). Dietary iron concentrations positively correlated with the 
number of iron-laden cells in the SVF of eAT, as seen by Prussian blue staining (Fig. 2A). Using 
ICP-MS quantification, iron content per cell positively correlated with dietary iron (Fig. 2B; P < 
0.05, 35 ppm vs. 2,000 ppm; P < 0.05, 500 ppm vs. 2,000 ppm). There was also a significant 
increase in the total count of MFehi ATMs from low to average to high iron, with 7.6 x 104 , 1.1 
x 105 , and 1.5 x 105 per gram tissue, respectively (Fig. 2C; P < 0.05, 35 ppm vs. 500 ppm; P < 
0.05, 500 ppm vs. 2,000 ppm; P < 0.001, 35 ppm vs. 2,000 ppm). Neither MFelo ATMs nor 
adipocytes had an increase in iron content (Fig. 2, C and D). Adipocyte iron was quantified using 
both AAS and ICP-MS methods in two separate experiments to ensure rigor and reproducibility 
of this finding, with no significant differences between the two methods (data not shown). The 
size of the adipocytes was 1,017 ± 103, 1,004 ± 22, and 946 ± 97 𝜇𝜇m2, low to high iron 
respectively, with no significant difference between the groups. 
 
 
 
Fig. 1. Physiological and serum iron parameters from mice fed diets with varying levels of iron. 
C57BL/6J mice were given 8 wk of low (35 ppm), average (500 ppm), and high (2,000 ppm) 
iron diets. A–C: serum iron parameters such as serum iron (A) (n 5), transferrin saturation 
calculated as % iron/total iron-binding capacity (B) (TIBC; n 4 – 6), and hematocrit (C) (n 6) 
were quantified. D: body weight was recorded over the study course (n 18 –22). E and F: body 
composition (E) (n 6) and glucose tolerance (F) tests were performed after 8 wk on diet (n 6). 
For all studies, significant differences were identified using ANOVA and t-test, with the 
following P-value indicators: ***P < 0.001, ****P < 0.0001. NS, not significant. 
 
 
Fig. 2. Effect of 8 wk of iron diet feeding on adipose tissue macrophage (ATM; MFehi and 
MFelo) and adipocyte iron content. C57BL/6J mice were on 8 wk of low (35 ppm), average (500 
ppm), and high (2,000 ppm) iron diet. A: whole adipose tissue (AT) was fixed and sectioned, 
then stained with Prussian blue to visualize iron and counterstained with nuclear fast red. B–D: 
cells were sorted to quantify iron content per ATM (B) (n = 8 –10), ATMs per gram of tissue 
(C), and adipocyte iron content (D) (n 8 –10). For all studies, significant differences were 
identified using ANOVA and t-test, with the following P-value indicators: *P < 0.05, ***P < 
0.001. eAT, epididymal adipose tissue. NS, not significant. 
 
 
MFehi respond to high dietary iron by upregulating iron storage genes. To assess the 
transcriptional response to iron availability, MFehi, MFelo, and adipocytes were collected for 
gene expression from mice fed varying levels of dietary iron. Expression of iron-uptake genes 
Cd163 and Tfrc, iron processing Hmox1, and iron export Slc40a1 were greater in MFehi ATMs 
compared with MFelo ATMs across all concentrations of dietary iron (Fig. 3). Furthermore, 
MFehi were generally more M2 polarized, with lower expression of Itgax and Nos2 compared 
with MFelo. In response to excess dietary iron, the MFehi population had an increase in 
expression of iron-storage-associated genes Ftl1 and Fth1, significant by two-way ANOVA with 
a P < 0.01 between cell types and P < 0.01 between diets (Fig. 3). Lastly, in response to high 
dietary iron, the MFehi population expressed higher levels of Spic, a transcription factor required 
for development of iron-handling macrophages in the spleen and bone marrow (10). In contrast, 
MFelo ATMs had no change in iron-handling-gene expression levels due to increased iron (Fig. 
3). Similarly, there was no difference in adipocyte iron-handling genes upon dietary iron 
challenge, although a trend for an increase in Ftl1, Fth1, and Il6 was noted (Fig. 4). Importantly, 
Adipoq expression was not different between groups. 
 Excess peritoneal iron is taken up by ATMs, not by adipocytes. Iron absorption is 
regulated through the intestinal tract, limiting dietary iron administration by the absorptive 
capacity. IP iron administration provides a direct way to provide higher iron levels to the 
peritoneum in a more controllable manner. This method was used to demonstrate our proof-of-
concept that ATMs compensate for excess iron as IP iron administration circumvents some of the 
systemic and absorptive factors present with iron diet models. In iron-injected mice, there was a 
visible increase in SVF iron content by Prussian blue staining (Fig. 5A). MFehi had a significant 
increase in intracellular iron content (P < 0.0001), whereas MFelo ATM iron content did not 
change (Fig. 5B). Interestingly, the number of MFelo cells per gram eAT was decreased (by 6.7 x 
104 ; P < 0.05); whereas conversely, the number of MFehi cells/gram eAT was increased (by 1.3 
x 105 ; P < 0.0001; Fig. 5C). Most importantly, quantified by both AAS and ICP-MS, adipocyte 
intracellular iron was not altered by the acute high-dose injection of iron (Fig. 5D). 
 MFehi ATMs respond to an acute high dose of iron with alterations in iron-handling 
genes. The MFehi ATMs respond to iron injections by altering their iron-handling genes. Iron-
import genes Cd163 (P < 0.01) and Tfrc (P < 0.01) decreased, whereas the iron-storage gene 
Fth1 (P < 0.05), iron-metabolism gene Hmox1 (P < 0.01), and the iron-export gene Slc40a1 (P < 
0.0001) were all increased (Fig. 6). Interestingly, in ANOVA analysis comparing the effect or 
the iron injection to the cell type, the iron effect drove the significant difference for all genes 
except Fth1. This is in contrast to MFelo, which showed no significant difference in any of the 
iron-handling genes in response to IP iron (Fig. 6). Reflecting their unaltered iron content, 
adipocytes did not have significant changes in the iron-handling genes Fth1 or Ftl1 (although 
there was a trend toward an increase), but they did have an elevation of Hmox1 (P < 0.05) and 
Slc40a1 (P < 0.01) (Fig. 7). Importantly, Adipoq and Il6, indicators of inflammation and 
dysfunction in adipocytes, were unchanged. 
 ATM cell counts respond to iron injection. The increase in count of MFehi ATMs may be 
explained by three primary mechanisms: 1) Monocytes are recruited and become MFehi ATMs, 
2) MFelo ATMs take up enough excess iron to essentially convert into MFehi cells, and 3) MFehi 
ATMs undergo cellular proliferation. We used the cell tracer PKH26 to address the first two 
possibilities. PKH26 is readily taken up by phagocytic cells and can be used to mark resident 
macrophages in peritoneal tissues by IP injection. Therefore, any PKH26- stained (PKH+) cell 
detected at the end of the study must have been present at the time of PKH26 injection. In 
contrast, an increase in PKH26-negative (PKH-) represents monocyte-derived macrophages 
recruited after the time of PKH26 injection. Reciprocal changes in counts of PKH MFehi or 
MFelo ATMs could indicate a shift between the two populations. We combined PKH26-mediated 
cell tracing with the 1-wk iron injection model to understand whether changes in the ATM cell 
counts were due to shifts in iron-containing populations or due to monocyte recruitment. At 1 wk 
after iron injection, 78% of all macrophages were PKH positive. The count of resident PKH 
MFelo ATMs decreased by 7.1 x 104 cells/gram tissue, and PKH MFehi ATMs increased by 1.1 x 
105 cells/gram tissue (Fig. 8A). This shift accounted for 83% of the total difference in MFehi 
(Fig. 5C). Of the recruited PKH- ATMs, there was no difference in MFelo ATMs. Interestingly, 
almost no MFehi macrophages were recruited in the absence of iron injection; however, 2.0 x 104 
PKH- MFehi ATMs/gram tissue were recruited upon iron injection (Fig. 8B; P < 0.001). On the 
basis of these results, monocyte recruitment accounts for 17% of the increase in MFehi in 
response to iron injections. Thus, our PKH studies reveal that shifts in ATM populations from 
MFelo to MFehi ATMs and monocyte recruitment fully account for the increase in MFehi 
following iron injection. 
 Iron uptake by ATMs is associated with M2 polarization. MFelo incorporation into the 
ferromagnetic fraction accounts for the majority of the increase in MFehi population following 
iron injection. Because the MFelo have reduced M2-like phenotype compared with MFehi, we 
hypothesized that their incorporation into the MFehi pool would shift the overall polarization 
state of the MFehi population to lower expression of M2-associated proteins. However, the 
opposite was true; in iron-injected mice, the MFehi ATMs had a decrease in cells positive for 
inflammation-associated surface markers (CCR2, CD11c) and an increased in cells with M2-
associated marker CD206 (Fig. 8, C–E). In contrast, there was a decrease in the count of MFelo 
ATMs positive for CCR2 and CD11c and no change in CD206 (Fig. 8, C–E). The findings 
indicate that iron uptake does not drive an inflammatory profile in macrophages MFehi cells, 
whereas it does in MFelo. Thus, even with MFelo incorporation into the MFehi population, the 
MFehi profile is even more M2-like post iron injection. 
 
 
Fig. 4. Adipocyte gene expression after 8 wk on iron diets. C57BL/6J mice were on 8 wk of low 
(35 ppm), average (500 ppm), and high (2,000 ppm) iron diet. A–G: iron-handling genes were 
quantified by RT-PCR (n 4 –5). For all studies, significant differences were identified using 
ANOVA and t-test. NS, not significant. 
 
Discussion 
 
 Reflecting the field’s current interest in macrophage polarization and iron handling by 
tissue-associated macrophages, we challenged MFehi ATMs with excess iron to investigate their 
functional role in maintaining AT iron levels. We approached this by supplying iron through a 
dietary route as well as direct IP injection. Dietary iron provision has commonly been used in 
other studies, often over a course of 8 wk, and with nonheme sources of iron because mice 
cannot absorb heme iron (8). Although systemic iron loading does occur consistently in dietary 
iron studies, the metabolic impact has been variable. McClain and colleagues provided high-, 
normal and low-iron diets (20,000 mg/kg, 330 mg/kg, and 7 mg/kg carbonyl iron, respectively) 
to C57BL/6 mice for 8 wk and observed a 40% decrease in Tfrc in adipocytes, 30% decrease in 
Adipoq, and an overall decrease in fat mass and increase in lean mass (9). These changes were 
associated with increased oxygen consumption by high-iron-diet mice and were adiponectin 
dependent. However, in our studies, we saw no impact of dietary iron on body weight or fat 
mass. We also noted no impact on glucose tolerance or difference in adipocyte gene expression. 
The most likely explanation for this difference is that our high-iron-diet model had 10-fold lower 
iron than the McClain study. To confirm iron loading, we quantified serum iron and transferrin 
saturation, and the increased iron levels were further confirmed by the increased iron content we 
saw in MFehi ATMs themselves. We recognized that the adipocyte iron content had high 
variability. This may be due to the need to standardize the iron quantification to cellular protein. 
Furthermore, variability in adipocyte iron content appears to be a common finding in this type of 
study (3). A second concern with this technique is the possibility that high-iron adipocytes are 
lost during the adipocyte collection process, selecting for adipocytes that are not iron loaded. 
However, at this time, there are no alternative methodologies for collecting adipocytes. Even 
given these limitations, our studies highlight the fact that MFehi macrophages in AT appear to 
take on the role of dealing with changes in local iron content. 
 We were interested in the proof-of-concept that MFehi ATMs accommodate for excess 
iron. Therefore, we gave iron-dextran at supraphysiological doses. Even as a model of excess 
iron, iron-dextran injection is medically relevant, as both iron-dextran and superparamagnetic 
iron oxide nanoparticles have been commonly used in humans to treat anemia and interestingly, 
accumulate in AT (16, 24). Iron-dextran is processed in a similar manner to hemoglobin iron, 
and has not been associated with cardiac dysfunction in C57BL/6 mice, presumably because they 
are able to excrete some of the excess iron in the feces (22). The type of iron processed by 
macrophages also influences their phenotype and could explain some of the contradictions 
between studies describing “iron-cycling” macrophages in vitro and different tissues. In tissues 
closely associated with the reticular system, such as spleen, vasculature, and muscle, heme-
associated iron is abundantly recycled by macrophages. Heme uptake liberates ferrous iron, and 
M2 macrophages respond by enhancing their oxidative stress pathways, Hmox1, and Fpn (4). In 
fact, CD163hi macrophages (Mhem) have been described as being protected from oxidative stress 
and less prone to lipid accumulation (2). In these systems, the recycling of iron from heme can 
be provisional to red blood cell production or wound healing, and the degradation process is 
inherently anti-inflammatory. However, most in vitro studies of macrophage iron handling have 
been performed with sources of ferric iron or transferrin-bound iron. AT is known to have very 
low levels of hemolysis. Therefore, we postulated that transferrin-bound iron is the primary 
source of iron for macrophages, whether from serum or adjacent cells, but this area warrants 
further analysis. 
 
 
 
 
Fig. 5. Effect of iron injection on adipose tissue macrophage (ATM; MFehi and MFelo) and 
adipocyte iron content. C57BL/6J mice were given an IP injection of 5 mg/kg iron-dextran 1 wk 
prior to euthanization. A: whole adipose tissue (AT) was fixed and sectioned, then stained with 
Prussian blue to visualize iron and counterstained with nuclear red. B–D: cells were sorted to 
quantify iron content per ATM (B) (n = 6), ATMs per gram of tissue (C) (n = 7), and adipocyte 
iron content (D) (n = 18). For all studies, significant differences were identified using ANOVA 
and t-test, with the following P-value indicators: *P < 0.05, ****P < 0.0001. NS, not significant. 
 
 Macrophages have been co-opted by many tissues to perform homeostatic functions 
outside of their typical immunological role. What is especially unique about these functions is 
that they allow for fine-tuned hemostatic regulation in tissues, often uncoupled from systemic 
physiology. For example, Corna et al. (7) used a macrophage-specific Fpn knockdown model in 
muscle damage. Even though the macrophages became iron loaded, they still accumulated at the 
site of damage and did not become oxidatively stressed. Importantly, in this model in which 
export of iron was impaired, myofiber regeneration was limited. In these studies, changes in 
expression levels of iron-associated genes in the muscle were not associated with changes in 
systemic iron homeostasis, indicating that there was an independent microenvironmental 
homeostasis between the tissue and resident macrophages. Similarly, in human atherosclerotic 
plaques, M2 macrophages process the iron released from hemolysis (1). Our results indicate that 
ATMs respond to excess iron, preventing iron overload in adipocytes. Even though adipocytes 
had increased expression of Slc40a1, the gene for the iron exporter ferroportin, and trends in 
Fth/Ftl, they had no increase in intracellular iron or inflammatory markers. So, even if the 
adipocytes did uptake iron, they were able to release this iron, and it was primarily taken up by 
MFehi. Interestingly, with acute iron injection, the MFehi had an M2-like iron-cycling phenotype 
(i.e., increased Tfrc, Slc40a1) (Fig. 6), whereas, in the chronic iron diet studies, MFehi mainly 
had increased expression of M1-like iron-storage genes Fth1/Ftl1 (Fig. 3). However, in both 
contexts, MFehi ATMs accrued higher levels of iron. This may indicate a temporality to the 
response of these ATMs to take up and store iron effectively. 
 The functional adaptability of macrophages has been linked to their phenotypic 
flexibility. Generally, the polarization state of macrophages is associated with different responses 
to iron: M1 macrophages dogmatically sequester iron as a bacteriostatic mechanism, and M2 
macrophages take up and release iron quickly. Studies have demonstrated that iron handling by 
macrophages can be impacted simply by altering their polarization stimuli (6, 25). However, 
there is a complex and reciprocal relationship between the phenotype of macrophages and their 
response to iron. For example, when macrophages are iron loaded because of Fpn deficiency, 
they respond to inflammatory stimulation with increased inflammatory cytokine expression (32). 
This effect is iron dependent, as it can be ameliorated in the presence of an iron chelator (32). In 
contrast, iron-loaded M2-polarized macrophages have high expression of iron-uptake and iron-
export genes, even in the presence of excess iron (6). The shift in iron-handling-gene expression 
can be tied back to a change in the binding of iron regulatory proteins in response to iron levels 
(31). In human M2-polarized macrophages, simply chelating intracellular iron can shift M2 
macrophages from an iron-cycling phenotype (higher import/ export genes) to an iron-storage 
phenotype (higher Ft) (17). Some of these differences are also seen in vivo. For example, the 
M2-polarized macrophages seen in atherosclerotic plaques have an iron-cycling profile, and they 
are quick to release iron rather than accrue it (1). The “iron-cycling” phenotype has been shown 
to play an important role in certain tissues because the macrophages can take up and release iron 
as needed and seemingly without an inflammatory response. Considering these findings, it is 
surprising that the iron-storing MFehi ATM population is not only very strongly M2-polarized 
but also maintains this polarization even while accumulating iron. We noted that MFehi ATMs 
were able to take up and sequester the excess iron provided through diet or injection and are in 
line with the macrophage response in muscle damage, in which Fpn knockout macrophages load 
iron, even without oxidative stress (7). In fact, the M2 macrophage phenotype in tissues may be 
more complex than the stereotypical iron-handling dichotomy described for M1 and M2. We 
observed an increase in Fth in response to iron injection, reflecting a protective response by 
MFehi ATMs. Furthermore, even with iron loading, MFehi ATMs did not take on a more 
inflammatory profile. This contrasts studies in liver and alveolar macrophages, in which iron 
loading of macrophages is associated with increased inflammation (29). Indeed, comparing 
resident macrophages from different tissues highlights the adaptability and specification of 
macrophages. Our understanding of the iron-cycling phenotype of the MFehi ATMs is limited by 
our inability to assess iron-related proteins specifically in these cells because of their low 
numbers. This restricts us to the use of flow cytometry and gene expression to assess the 
phenotype of the cells rather than Western blot. In future studies, it would be ideal to develop a 
method for assessing iron-response protein levels because a cell’s iron response is primarily 
driven through the iron-response protein system, such that level of these proteins is the most 
sensitive and accurate way of determining the iron status of a cell. Despite this limitation, the 
observation that MFehi take up excess iron and yet remain M2 polarized suggests a specialized 
function for this unique cell population. 
 
 
Fig. 6. Effect of iron injection on adipose tissue macrophage (ATM; MFehi and MFelo) gene 
expression. C57BL/6J mice were given an IP injection of 5 mg/kg iron-dextran 1 wk before they 
were euthanized. A–F: iron-handling genes were quantified by RT-PCR for MFelo and MFehi 
ATMs (n 6). For all studies, significant differences were identified using ANOVA and t-test, 
with the following P-value indicators: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NS, 
not significant. 
 
 
Fig. 7. Effect of iron injection on adipocyte gene expression. C57BL/6J mice were given an IP 
injection of 5 mg/kg iron 1 wk before they were euthanized. A–H: adipocytes were isolated, 
RNA prepared, and iron-handling genes quantified by RT-PCR (n 6). For all studies, significant 
differences were identified using ANOVA and t-test, with the following P-value indicators: *P < 
0.05, **P < 0.01. NS, not significant. 
 
 
Fig. 8. Effect of iron injection on adipose MFehi and MFelo inflammatory markers and 
recruitment. Adipose tissue macrophages (ATMs) were marked with PKH26 before iron 
injection to assess for population shifts as quantified by the resident PKH ATMs (A) and 
monocyte recruitment as quantified by PKH- ATMs (B) (n = 7). MFehi and MFelo polarization 
response to iron injection was quantified by cell-surface inflammatory markers, including M1-
associated CCR2 (C) and CD11c (D), as well as M2-associated CD206 (E) (n = 4 – 6). For all 
studies, significant differences were identified using ANOVA and t-test, with the following P-
value indicators: *P < 0.05, **P < 0.01, ***P < 0.001, ****P  0.0001. eAT, epididymal adipose 
tissue. NS, not significant. 
 
 
Following iron injection, there was an increase in MFehi per gram of tissue, with a reciprocal 
decrease in MFelo. Increased MFehi were also observed with iron diets, but the effect was more 
subtle. In fact, PKH26 staining of resident macrophages allowed us to deduce that the enlarged 
MFehi population was likely because of MFelo cell “conversion” to MFehi. The MFehi population 
is defined by positive magnetic sorting, but relative to MFelo, MFehi were also found to have 
extreme M2 polarization by gene expression and flow cytometry (23). With more cells adhering 
to the magnet, we cannot conclude if the uptake of iron by MFelo represents a conversion in 
ATM subtypes or simply paramagnetic qualities of MFelo because of iron uptake. There are no 
known methods that would allow us to trace MFehi versus MFelo. However, we would predict 
that if the MFehi population became enriched with MFelo, the average polarization profile would 
shift away from the extreme M2 polarization. What we found was that overall polarization 
markers indicate the MFehi are on average more M2 polarized with iron uptake, even with newly 
incorporated MFelo cells. This suggests that the MFelo cells incorporated into the MFehi pool are 
not simply paramagnetic but may be changing their actual phenotype and function. This 
contradicts other studies that show inflammatory polarization of macrophages with iron 
treatment. Therefore, we hypothesize that a unique conversion of macrophages may be occurring 
with excess iron in adipose tissue. Interestingly, we noted an increase in the expression of Spic in 
MFehi in our iron diet studies. This protein is developmentally required for the development of 
two types of iron handling macrophages: splenic red pulp macrophages and bone marrow 
macrophages. This may demonstrate a mechanism by which either MFelo ATMs or recruited 
monocytes are converting to the MFehi phenotype. 
 Our studies further explore a role for a subtype of ATMs in taking up and processing iron 
to protect adipocytes from iron overload. Using dietary and IP iron overload we demonstrated 
that MFehi ATMs are able to fully compensate for excess iron in the AT. As part of this response, 
the MFehi pool expands to include iron-loaded MFelo that have shifted to a stronger M2 
phenotype. Furthermore, circulating monocytes are also recruited to the MFehi pool. These 
findings expand our understanding of iron handling by macrophages beyond the classic M1/M2 
paradigm. In conjunction with other studies in the field, this further demonstrates the importance 
of fine-tuned iron regulation for adipocytes and the intimate homeostatic relationship between 
macrophages and adipocytes. It is thought that iron release by M2 macrophages allows for 
cellular proliferation. For example, in coculture studies, media from human M2-polarized cells 
supported cancerous growth, and this effect was reversible with iron chelation (25). Similarly, 
studies have shown that iron is necessary for adipogenesis (18). Therefore, future studies in this 
area will look at the interaction of resident macrophages in AT and their role in iron homeostasis 
in the context of adipogenesis. 
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